Hematologic Malignancies
📧 Sign up to get email alerts when something new happens for Hematologic Malignancies.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2012-01-19Clinical Trial Update: Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study [NA]
This clinical trial update describes a pharmacokinetic study evaluating Busulfan and Fludarabine as conditioning before allogeneic stem cell…
-
FDA approval · 2011-11-14FDA Approved: KEPIVANCE — Supplemental Application (Swedish Orphan Biovitrum AB (publ))
The FDA approved a supplemental application for Kepivance (palifermin) from Swedish Orphan Biovitrum AB (publ). The supplemental approval up…
-
CLINICAL_TRIALS trial_result · 2011-10-19Clinical Trial Update: Dose Escalation Study of ARQ 621 in Adult Patients With Metastatic Solid Tumors and Hematologic Malignancies [Phase 1]
Phase 1 dose-escalation study of ARQ 621 in adults with metastatic solid tumors and refractory/relapsed hematologic malignancies has complet…
-
CLINICAL_TRIALS trial_result · 2011-09-02Clinical Trial Update: Nonmyeloablative Stem Cell Transplantation With CD8-depleted or Unmanipulated Peripheral Blood Stem Cells (PBSC) [Phase 2]
This update reports the completion of a Phase 2 clinical trial evaluating nonmyeloablative stem cell transplantation using CD8-depleted or u…
-
CLINICAL_TRIALS trial_result · 2011-09-02Clinical Trial Update: Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease [Phase 2]
Phase 2 clinical trial evaluating mesenchymal stem cell infusion to prevent graft rejection and graft-versus-host disease in hematologic mal…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: Conditioning Regimen Before Infusion of Allogeneic Hematopoietic Stem Cells
This update reports on the completion of a clinical trial evaluating a conditioning regimen before infusion of allogeneic hematopoietic stem…
-
CLINICAL_TRIALS withdrawal · 2011-04-08Clinical Trial Update: Treatment of Patients With Donor Lymphocytes Sensitized by Antigens Expressed by the Host [Phase 2]
A Phase 2 trial evaluating donor lymphocytes sensitized by host antigens was withdrawn. The sponsor was Hadassah Medical Organization.
-
CLINICAL_TRIALS trial_result · 2010-10-08Clinical Trial Update: Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation [Phase 3]
This trial update describes a Phase 3 study evaluating Thymoglobulin (anti-thymocyte globulin) in unrelated donor hematopoietic progenitor c…
-
CLINICAL_TRIALS trial_result · 2010-10-01Clinical Trial Update: Allo After Allo Stem Cell Transplantation Following Relapse After Allogeneic Transplant in Haematological Malignancies: Retrospective Results of the GETH
Retrospective results from the GETH examine outcomes of performing another allogeneic stem cell transplantation in patients with hematologic…
-
CLINICAL_TRIALS trial_result · 2010-08-25Clinical Trial Update: Study of the Tolerability, Safety, and Pharmacokinetics of CRA-024781 in Cancer Patients [Phase 1]
This Phase 1 clinical trial update assesses the tolerability, safety, and pharmacokinetics of CRA-024781 in cancer patients and indicates th…
-
CLINICAL_TRIALS trial_result · 2010-06-03Clinical Trial Update: Comparison of Peripheral Blood Stem Cell Transplantation With Bone Marrow Transplantation for the Treatment of Serious Hematological Malignancies [Phase 3]
A Phase 3 trial comparing peripheral blood stem cell transplantation with bone marrow transplantation for serious hematologic malignancies h…
-
CLINICAL_TRIALS research · 2009-12-23Clinical Trial Update: Exercise During Chemotherapy for Patients With Hematological Malignancies [Phase 3]
Phase 3 clinical trial evaluating exercise during chemotherapy for hematologic diseases and hematologic malignancies; current status is unkn…
-
CLINICAL_TRIALS research · 2009-07-08Clinical Trial Update: Randomized Study of ATG for Graft Versus Host Disease (GVHD) Prevention in Paediatric Patients Given an Unrelated Donor Stem Cell Transplantation [Phase 3]
Phase 3 randomized trial evaluating anti-thymocyte globulin (ATG) for prevention of graft-versus-host disease in pediatric patients receivin…
-
CLINICAL_TRIALS trial_result · 2009-05-05Clinical Trial Update: A Phase 1 Study of MKC-1 in Patients With Refractory Hematologic Malignancies [Phase 1]
This document reports a Phase 1 trial of MKC-1 in patients with refractory hematologic malignancies, including myelodysplastic syndromes and…
-
CLINICAL_TRIALS trial_result · 2009-04-06Clinical Trial Update: Risk of Hepatitis B Virus Reactivation in Patients Undergoing Allografting
This clinical trial update discusses the risk of hepatitis B virus reactivation in patients undergoing allogeneic transplantation. The trial…
-
CLINICAL_TRIALS trial_result · 2009-03-13Clinical Trial Update: Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell Transplantation [NA]
This clinical trial update reports the completion of a study evaluating darbepoetin alfa (Aranesp) following allogeneic stem cell transplant…
-
CLINICAL_TRIALS trial_result · 2009-01-27Clinical Trial Update: Prevention of Catheter-Related Bloodstream Infection in Patients With Hemato-Oncological Disease [Phase 3]
Phase 3 trial evaluating prevention of catheter-related bloodstream infection in patients with hematologic malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2007-10-04Clinical Trial Update: MiniMUD Study - Unrelated Reduced Intensity Conditioning With Treosulfan® for Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies [Phase 2]
Phase 2 clinical trial evaluating unrelated reduced-intensity conditioning with Treosulfan for allogeneic stem cell transplantation in patie…
-
CLINICAL_TRIALS trial_result · 2007-09-20Clinical Trial Update: Prevention of Catheter-Related Bloodstream Infection in Patients With Haemato-Oncological Disease [Phase 3]
A Phase 3 clinical trial completed evaluating prevention of catheter-related bloodstream infection in patients with hematologic malignancies…
-
CLINICAL_TRIALS trial_result · 2006-09-08Clinical Trial Update: Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of Streptococcal Sepsis After Hematopoietic Cell Transplantation [Phase 3]
Phase 3 trial comparing prophylactic versus empirical vancomycin to prevent streptococcal sepsis after hematopoietic cell transplantation ha…